Merck announced on Wednesday a supply and purchase agreement with Singapore that will ensure access to its experimental oral COVID-19 antiviral drug, making Singapore the latest Asian country to seek supplies.
Molnupiravir, the first oral antiviral medication for COVID-19, is designed to introduce errors into the coronavirus’s genetic code. Merck is requesting that the pill be approved by the US Food and Drug Administration.
Singapore’s health ministry confirmed the agreement, but declined to comment on the number of doses purchased due to commercial sensitivities.
According to the ministry, molnupiravir will be available for use after Merck, also known as MSD Pharma in Singapore, submits data to the Health Sciences Authority (HSA) and obtains approval for use in Singapore.
Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…
https://youtu.be/mdl3AFFFcuk?si=i2cYzTX7WJ-z6wRp Does Chyawanprash Help in Cough & Cold? Exploring Its Benefits and Efficacy Chyawanprash, a…
Walk In Winter: In winter, the time from 7:00 AM to 9:00 AM is considered…
Does Maida Stick To Your Gut Lining: In this article, we debunk the common myth…
https://youtu.be/4NTKSfNf1TM?si=Y4xkEOKDUvqpIEZt The Disadvantages of Heating Packaged Milk Milk is a staple in many households and…
A recent study has revealed a growing mental health crisis among teenagers globally, with nearly…